Company / Current Liabilities
Ligand Pharmaceuticals, Inc. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$37.4M
FY2025
5-year range
$16.8M / $98.8M
FY2021-FY2025
Trend
+0.9%
vs FY2024
Sector context
#164 of 213
Health Care
What the data says
Ligand Pharmaceuticals, Inc.'s current liabilities of $37M is lower than 77% of companies in the Health Care sector (FY2025). Current Liabilities has fluctuated over the past 10 years, ranging from $17M in FY2023 to $239M in FY2017.
Based on SEC 10-K filings.
$37M in FY2025 with a 5-year CAGR of -17.9%.
Increased from $17M to $37M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -27.6%
- 5-Year CAGR
- -17.9%
- 10-Year CAGR
- -
Sector benchmark
Top 23% in Health CareTop 23% of 213This company $37.4M Sector average $1.6B
▼
-97.6% below sector average
Key checks
Key Insights
- 5-year CAGR of -17.9%, indicating a declining trend.
- In FY2025, current liabilities increased 0.9% year-over-year.
- Ranks #164 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2017.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $37.4M | +0.9% |
| FY2024 | $37.1M | +121.1% |
| FY2023 | $16.8M | -83.0% |
| FY2022 | $98.8M | +137.2% |
| FY2021 | $41.7M | -58.4% |
| FY2020 | $100.1M | +488.8% |
| FY2019 | $17.0M | -79.3% |
| FY2018 | $82.2M | -65.6% |
| FY2017 | $238.9M | +5.2% |
| FY2016 | $227.1M | +1.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026